Internal Medicine, Endocrinology, Diabetes, & Metabolism · Louisville, KY
NPI
1649265059
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
210 E Gray St Ste 605
Louisville, KY, 40202
Phone (502) 559-3636
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
17,908 services
Medicare patients, 2024
760
Average age 70
Drug cost, 2024
$6.0M
17,142 prescriptions
Company payments, 2025
$355
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mehdi Poorkay was code 99214 (office e&m - established), 865 times for 592 patients. In total Mehdi Poorkay billed 17,908 services in 29 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 865 | 592 | $88.53 | $77K |
| 36415 Venipuncture Blood Collection | Office | 626 | 412 | $8.59 | $5,376 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 421 | 374 | $13.15 | $5,537 |
| 99233 Hospital E&M - Subsequent | Facility | 377 | 70 | $94.02 | $35K |
| 95251 Test - Miscellaneous | Office | 125 | 99 | $26.01 | $3,251 |
| 99215 Office E&M - Established | Office | 119 | 112 | $117.59 | $14K |
| 83036 Blood Count | Office | 84 | 79 | $9.25 | $777 |
| 99222 Hospital E&M - Initial | Facility | 81 | 77 | $103.01 | $8,344 |
| 82947 Clinical Chemistry | Office | 32 | 31 | $3.85 | $123 |
| 99205 Office E&M - New | Office | 16 | 16 | $137.07 | $2,193 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $134.34 | $1,746 |
By year: 2022 $140K for 15,353 services; 2023 $143K for 14,503 services; 2024 $157K for 17,908 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 626 | 412 | $8.59 | $5,376 |
| 83036 Blood Count | 84 | 79 | $9.25 | $777 |
| 82947 Clinical Chemistry | 32 | 31 | $3.85 | $123 |
Medicare prescription drug claims, 2024
In 2024, the drug Mehdi Poorkay prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,130 prescriptions and refills. In total Mehdi Poorkay wrote 17,142 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,130 | 5,529 | 627 | $26K |
| Atorvastatin Calcium Generic | 1,244 | 3,353 | 446 | $9,884 |
| Ozempic Semaglutide | 1,051 | 1,639 | 255 | $1.5M |
| Metformin Hcl Generic | 886 | 2,349 | 290 | $5,240 |
| Glimepiride Generic | 537 | 1,418 | 190 | $4,813 |
| Pravastatin Sodium Generic | 509 | 1,350 | 162 | $5,472 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 497 | 1,180 | 199 | $101K |
| Rosuvastatin Calcium Generic | 435 | 1,230 | 157 | $4,447 |
| Nateglinide Generic | 392 | 904 | 158 | $25K |
| Synthroid Levothyroxine Sodium | 378 | 1,019 | 105 | $35K |
| Jardiance Empagliflozin | 377 | 789 | 116 | $453K |
| Novolog Flexpen Insulin Aspart | 343 | 725 | 150 | $129K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 325 | 857 | 117 | $2,306 |
| Humalog Kwikpen U-100 Insulin Lispro | 303 | 656 | 128 | $129K |
| Metformin Hcl Er Metformin Hcl | 287 | 744 | 106 | $2,936 |
Brand drugs: 7,071 claims; generic drugs: 8,975 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mehdi Poorkay $355 ($355 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sanofi-Aventis U.S. LLC with $126.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.